Foghorn Therapeutics Inc. FHTX NASDAQ

Foghorn Therapeutics Inc. (FHTX) reported total assets of $198.1M and total liabilities of $306.6M for quarter ending 2025-12-31, resulting in total equity of $-108.5M.

The company held $158.89M in cash and short-term investments. Total debt stood at $41.27M, with net debt of $-39.61M. The Debt-to-Equity (D/E) ratio was -0.38 (conservative).

Current ratio is 2.73, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of -0.38, current ratio of 2.73 — balance sheet is strong
• MOAT (35/100) — Total assets $198.1M and equity $-108.5M support the company's competitive scale
• VALUE (91/100) — Debt-to-Equity -0.38 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 60/100 with 4/7 criteria passed.